Jane Street Group LLC trimmed its holdings in Inogen, Inc. (NASDAQ:INGN – Free Report) by 83.1% during the third quarter, ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...

Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog. Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which ...

Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

However, it is mandatory that the concentrator at least is capable of delivering at least 90% concentrated Oxygen supply. The price range of Oxygen concentrators begins from Rs 40000 and goes upto ...

Inogen, Inc. (NASDAQ: INGN) is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter ...

StockNews.com cut shares of Inogen (NASDAQ:INGN – Free Report) from a buy rating to a hold rating in a research note published on Friday. Separately, Needham & Company LLC reaffirmed a “hold” rating ...

Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...